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Abstract
Clinicians benefit from online treatment planning systems, through off-
site accessibility, data sharing and professional interaction. As well as en-
hancing clinical value, incorporation of simulation tools affords innovative
avenues for open-ended, multi-disciplinary research collaboration. An ex-
tensible system for clinicians, technicians, manufacturers and researchers
to build on a simulation framework is presented. This is achieved using a
domain model that relates entities from theoretical, engineering and clin-
ical domains, allowing algorithmic generation of simulation configuration
for several open source solvers.
The platform is applied to Minimally Invasive Cancer Treatments
(MICTs), allowing interventional radiologists to upload patient data, seg-
ment patient images and validate simulated treatments of radiofrequency
ablation, cryoablation, microwave ablation and irreversible electropora-
tion. A traditional radiology software layout is provided in-browser for
clinical use, with simple, guided simulation, primarily for training and
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research. Developers and manufacturers access a web-based system to
manage their own simulation components (equipment, numerical models
and clinical protocols) and related parameters.
This system is tested by interventional radiologists at four centres, us-
ing pseudonymized patient data, as part of the Go-Smart Project (http://gosmart-
project.eu). The simulation technology is released as a set of open source
components (http://github.com/go-smart).
Figure 1: Graphical abstract
1 Introduction
Computer simulation technology can benefit clinicians and patients through
training, education and planning [45]. For greatest effect, however, direct co-
operation between clinicians, engineers and computational scientists is required
[45]. This paper presents a system of pre-packaged ancillary tools, including
a web-based radiological interface, image manipulation and a simulation archi-
tecture. Such an approach reduces the required collaboration skill-set to those
directly relevant to the research or training at hand, and can remove web devel-
opment as a limiting factor in web-based clinical training, commercial product
development and simulation research.
In surgical training, acquisition of basic skills is moving from the operating
theatre to educational settings, building an increasing need for testable, exten-
sible educational surgical software. Moreover, experienced clinicians must gain
experience using new technology as it is introduced, another important applica-
tion of computational and non-computational simulation [20]. In general, pre-
dicting the outcome of minimally invasive therapies, particularly those involving
thermal ablation, remains challenging due to the many factors influencing the
procedure. Providing a platform for such training in a specific discipline requires
engagement of both junior and senior clinicians for these reasons.
Manufacturers must also be involved: their consideration of clinicians’ needs
is crucial, and includes areas potentially outside core competencies, such as
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software user experience [69]. This can create a significant cost and personnel
burden in a green-field project. Reduction of newly designed interfaces can help
avoid unpredicted challenges, benefiting from both user familiarity and a history
of integrated feedback. By engaging with established tools, manufacturers gain
insights into clinician and researcher behaviour at a preliminary stage, prior to
costly investment in a software development or support infrastructure. Struc-
tured engagement of manufacturers with practitioners in simulated settings is
encouraged [69].
The translational link between researchers and clinicians is also an essential
element to support: the existence of a marked gap between research outcomes
and implementation is well-established [27]. Encouraging awareness of devel-
oping best practice and technical evolution is therefore an important role of
those engaged in establishing it [27]. Within clinical research itself, the need for
research-relevant information systems has been identified as one of a number of
research challenges, as are infrastructure investment and training. Public par-
ticipation, also, is essential and can be impeded by lack of standardization and
conflicts of interest. Together, these emphasize the need for vendor-independent,
research-supporting IT frameworks, complementing clinical skill-sets and facil-
itating effective interaction between the worlds of research and practice [76].
The importance of effective and well-documented clinical trials is emphasized
by another professional communication gap - that between trial outcomes and
other forms of predictive study. Such discrepancies may arise from publication
bias, inaccessibility of animal study registers and methodological limitations,
amongst other factors [59]. A closer loop must be established between clinical
triallists and experimentalists to ensure shortcomings in preliminary research are
identified and resolved [59]. Providing a simplified, standardized and accessible
online interface reduces the practical costs and obstacles to setting up a clinical
or pre-clinical trial, and to the cataloguing and sharing of trial results.
In contrast to offline, non-web-based systems, an online web-based inter-
face allows users in different institutions to interact on the same system, and,
in particular, clinicians to use parameters and models dynamically defined by
manufacturers and researchers. It also allows users to access data on their own
devices off-site, for example, when meeting. This is practical only with a web-
based system.
The project discussed in this work, the Go-Smart project [82], provides a
web platform for highly adaptable simulation of minimally invasive cancer treat-
ments. This avoids a computational system that represents a frozen point of
development, allowing new equipment, clinical protocols and numerical models
to be incorporated.
Underpinning this functionality is a domain model relating interventional
room practice, manufacturer equipment and numerical analysis. It provides a
framework for defining allowable combinations of entities, with a hierarchy of
simulation parameters contributed by each. This is exported as a single, con-
densed configuration file for the simulation server. Results are viewed through
an interactive, radiology-style web interface and may be validated against a
segmented lesion, if available.
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Clinicians interact with the system via a simple point-and-click interface
in the web-site, when launching a simulation through the radiological patient
management system. Entities may indicate certain parameters to be clinician-
specifiable (e.g. duration of optional intervention steps, needle location), and
the clinician is presented with a dynamically generated web-form. Technical
users may access an additional interface, providing lower-level control of the
parameters and properties of their contributed entities.
1.1 Novelty
This sytem is novel in several key respects:
− the approach to modelling general medical simulation problems, both
− technically, by combining clinician-input data with researchers’ sand-
boxed, uploaded computer code and parameters, through the Glossia
system, described below, and
− conceptually, through the Clinical Domain Model, described below,
which structures this approach.
Together these allow a far greater depth of interaction between researchers,
manufacturers and clinicians on a single platform than previously possible;
− 2D and 3D web visualization techniques, enabling a highly-responsive,
easy-to-use, web-based radiology platform, comparable to offline systems,
required for real-world clinician engagement;
− expansion and tuning of web-based image segmentation and registration
techniques to ensure consistent and reliable processing of organ-level ge-
ometry, required for real-world clinician engagement;
− building a range of existing, and novel, numerical models surrounding a
single medical application - Minimally Invasive Cancer Treatment (MICT)
- and demonstrating the effectiveness of this system, taking individual pa-
tient datasets uploaded and segmeneted by clinicians through to simula-
tion, and quantified model verification.
The Minimally Invasive Cancer Treatment simulation within the Go-Smart
project is dependent on the innovations above, and the results that particular
system can demonstrate have been shown by project authors.
However, the underlying technical and conceptual approach, applicable to
general clinical problems, is first described in detail here. Its outcomes in the
MICT application are shown to demonstrate this system’s effectiveness in en-
abling highly-effective, clinician-driven use of dynamically-defined simulation.
In the paper, we show a novel architecture that makes online collaboration
between researchers, manufactureres and clinicians possible, without the mod-
elling restrictions placed on researchers by existing systems.
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1.2 Application
The specific application under consideration is the web-based analysis of Mini-
mally Invasive Cancer Treatments (MICTs). MICTs, in the scope of the project,
comprise a set of methods for percutaneous tumor ablations under image guid-
ance. In this context, we have developed a workflow across a consortium of nine
partners, four clinical and five technical, that has been tested using incoming
patient data over several years. In addition, we have been supported in our
testing by input and feedback from external clinical users, MICT treatment
manufacturers and, as the framework design approach is intended to be more
broadly applicable, external biophysics researchers operating outside the MICT
domain.
MICTs are a growing set of techniques for ablating cancerous tumours with-
out the need for full surgical resection or when there are no surgical options.
Such techniques include radiofrequency ablation (RFA), microwave ablation
(MWA), cryoablation and irreversible electroporation (IRE), all of which are
performed using percutaneous needles. The specific mechanisms of action, and
underlying physics, are described in §3. As many of these techniques are becom-
ing established and new approaches are continually appearing, it is challenging
for interventional radiologists to gain and maintain familiarity with the available
equipment and indications. Nonetheless, clinicians must remain aware of the
changing field to provide optimal patient care - in RFA, experience has been
shown to be correlated to treatment outcomes [31]. Moreover, they must be
experienced in MICT selection and able to simulate or practice with new tools
prior to clinical use. While modality-specific planning tools exist (e.g. [62, 38]),
previously, there has been no effective tool for interventional radiologists (IRs)
to predict patient-specific outcomes of a treatment, allowing for various modal-
ities and equipment of various manufacturers.
This is a clinician-driven requirement to allow patient-specifci comparison
of approaches to treating a given tumour across multiple treatment modalities,
as comparison within a single modality is an artificial constraint to finding an
optimal treatment option.
The Go-Smart project seeks to rectify this, by providing a platform for clini-
cians to upload patient data, including CT and MRI images, then to plan, com-
pare and validate treatment options. For a complete, ergonomic environment to
be achieved, significant development has been undertaken: this encompasses im-
age segmentation, image registration, simulation, modelling and visualization,
brought together within a purpose-built scalable web framework. Validation
data, for quantifying the performance of the segmentation, registration, mod-
elling and simulation aspects, has been provided and reviewed by a series of
clinical partners.
A core feature of the Go-Smart framework is its extensibility. To maintain
pace with the state of the art going forward, additional mathematical models,
simulation codes, equipment and even modalities may be added through the
web interface, by independent researchers, technicians and manufacturers.
It is expected that the Go-Smart environment will provide a tool for indepen-
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dent evaluation of equipment, training of clinicians, collaboration on treatment
planning and medical research.
Even within existing MICTs, clinician experience is a highly determining
factor for patient outcomes. Boundaries of tissue necrosis are hard to predict
heuristically and medical simulation can help reduce patient exposure to out-
comes that are difficult to predict based clinical experience only. However, a
single platform representing a snapshot of technical development in a rapidly
changing field would quickly lose its relevance, and so the ability to incorporate
new technologies through the web interface is indispensible to this aim.
1.3 Background
In the early 2000s, distributed computing projects began to appear in European
health-care research: NeuroGrid [25], MammoGrid [5] and GEMSS [14], for in-
stance, all began around this time. Applying principles of distributed computing
in this sphere provided effective use of computational resources between insti-
tutions and opportunities for international collaboration. Complementing stan-
dalone tools that provide medical image and/or simulation analysis toolchains,
such as SimBio [22], COPHIT [10], BloodSim [58], euHeart [73], IMPPACT [57],
or, much earlier, RAPT, newer platforms exist to bring analysis to a distributed
setting, in some cases adapting existing standalone frameworks [13, 72]. The ex-
tension to a generic toolchain using scientific middleware is a challenge that has
been impeded by closed extensions in proprietary tools [72], and evolutionary
developments have moved closer to open, standardized protocols, incorporating
web technologies for improved quality of service [21]. A more extensive overview
of international computational projects in biomedicine is provided in [44] and
[61].
Matching earlier distributed tools to a clinically usable web-based interface
is an additional challenge, and one that has more recently been addressed with
projects such as Aneurist [56] or neuGRID [61]. Simulation and patient-specific
analysis algorithms may be later extensions to distributed data projects, as in
the Health-e-Child and Sim-e-Child projects, respectively [23, 33, 51]. Other
possible extensions include the expansion of user-facing web services [28] and
broadened application of simulation tools through intercontinental amalgama-
tion of data sources [75, 35]. Several such extensions may be seen in evolution
between projects, adding significant value to existing tools [16].
Lessons learned from earlier distributed medical projects include the need for
simple, widely-used standards, quality assurance, community building and good
governance [80]. In particular, open infrastructure, specifically middleware, is
a key component of successful projects [7, 6, 83, 3]. Adaptable open standards
for defining simulation models, such as CellML, FieldML and SBML, are also
important. However, they are not, in themselves, a panacea for providing mod-
elling compatibility [36, 35, 50].
Many of these projects will be focused on medical research, rather than
the clinical context. However, bridging the research-application gap within a
platform provides opportunities to augment clinical decision making with pre-
6
dictive analysis, support clinical trial management, provide access to accumu-
lated knowledge and, potentially, enhance patient-clinician communication [63].
Web-based services may even allow upload and analysis of data from home-
monitoring systems, simultaneously providing a platform for patient support,
clinician review and computational analysis [37]. With external clinicians and
patients involved in platform use, a need arises for effective end-user engagement
through channels such as social media [67]. Ultimately, if such tools, especially
predictive simulation tools, are intended to inform medical procedure, an accept-
able clinical workflow incorporating the output analysis must be formed [79]. In
the research setting, an aim of web-based workflow tools, such as Galaxy [26],
is to enhance accessibility, reproducibility and transparency.
Simulation workflows can facilitate patient-specific predictive analysis, based
on the patient’s medical images and quantitative indicators [18]. Moreover,
they allow for both analysis and training to be incorporated into a web plat-
form [55, 42]. However, incorporating computational modelling into education
requires clarity around validation, documentation, copyright, confidentiality,
duration and processing demands [42]. Simulation workflows may be primarily
dynamically defined [54] or written in a more imperative, scripted manner [17].
While software such as Apache Taverna [32] and Galaxy [26] may provide very
flexible workflow definition toolkits, a need for toolkit interchangeability still
exists [68]. However, an established pattern for a number of medical simulation
applications is the interlinking of an online knowledge database to a toolchain
joining pre-processing, model creation, numerical solution and post-processing
[11].
Other considerations in recent projects include convenience (no installation
required for end-users), transparency, lightweight components, scalability and
maintainability [70]. Adaptability, facilitated through lightweight tooling and
a tight developer-stakeholder loop, is essential to account for the inevitable
changeability of requirements throughout a clinical computing project [30].
Where distributed biomedical projects had generally been grid-based, cloud in-
frastructure is increasingly supported, for example, in the CBRAIN and VPH-
Share projects [70, 12]. In particular, this allows extension of existing grid
projects to a broader audience [12]. Nonetheless, as cloud resources are often
run by third-party infrastructure as a service (IaaS) providers, quantitative com-
parison of cost and performance must be undertaken [15]. Within the Go-Smart
project, simulation tools are consequently designed to be flexible with respect
to deployment context.
While many of the existing projects have used an administrator-determined
or architect-determined workflow, web-based biomedical simulation design is a
growing approach. This is facilitated by a growth of workflow management
systems, which can provide a convenient ready-made back-end. Such systems
include the early Discovery Net, one of the first such systems, Triana, Apache
Taverna and Kepler [19]. While many such bioengineering, bioinformatics and
biomedical workflow systems now exist, it is less common to see such systems
with an integrated web-based interface for dynamic inclusion of third-party
workflows. Certain projects have based extended existing workflow packages
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to improve cloud functionality or user-friendly web support, such as the Tavaxy
project [2], combining the Galaxy system with the Taverna suite, WorkWays
providing a web gateway for Kepler [52], or GPFlow wrapping Microsoft BizTalk
and Human Workflow Services in a user-friendly scientific web interface [65]. In
an offline setting, the GIMIAS open source framework provides a set of offline
analysis and visualization tools that may be used inconjunction with Taverna
to build complete research workflows, or preliminary clinical workflows [47].
The CHIC project [74, 77] provides a general, web-based cancer multi-scale
modelling tool. They provide strong support for model adaptation and flexible
architecture, supported by Apache Taverna workflow management. Moreover,
this project incorporates human intervention steps in model execution and sup-
port probabilistic variables. They define the concept of hypermodels, which
may be created by expert users as a workflow combination of pre-defined hypo-
models through the web-based interface. Clinicians may execute upload patient
data and perform simulations through this interface. While this project forms
an important counterpoint to Go-Smart, the focus in the latter project is to-
wards integrating manufacturer use cases and basic research with clinical use,
by allowing the underlying hypomodels themselves to be created and managed
through the interface. The CHIC project builds on the broad adaptability of its
toolchain, allowing individual installations to provide new features. In the Go-
Smart case, the clinical domain model, described in §2.4, is used to provide an
opinionated framework, centred around medical interventions, but facilitating
the cooperative building of new simulation strategies in that context.
The VPH-Share project incorporates a number of disparate medical areas
in its flagship workflows: @neurIST, euHeart, VPHOP and Virolab. Online,
or offline, workflow composition is available through Taverna support [78]. Re-
searchers may access a diverse range of components, and a strong cloud focus
provides flexible capacity for computation and data storage [43]. Interactive
workflow steps are enabled through launching interactive interfaces, such as
GIMIAS, in a cloud-hosted virtual machine and providing web-based remote
desktop access. This enhances existing desktop applications through web acces-
sibility. Workflows may be developed through online tools such as OnlineHPC,
or offline with Taverna. VPH-Share is focused on providing a very general plat-
form supporting diverse research-driven workflows. In contrast, Go-Smart fo-
cuses on a radiologically-driven design, helping researchers bridge the discipline
gap by adapting and extending the analysis workflow at a low level through
scripting, or a high level through parameter adjustment and manipulation of
conceptual clinical components (§2.4). This ensures a comfortable, familiar ex-
perience for clinicians, while maintaining flexibility and a low barrier for entry
both to developers and high-level modellers.
Combining Go-Smart utilities with workflow management tools such as Tav-
erna or OnlineHPC (http://onlinehpc.com), or a web-based research and data
management tool such as VPH-Share, would provide useful future enhance-
ments, integrating benefits of each project.
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2 Methods
The Go-Smart distributed architecture is designed to ensure stability and scal-
ability of the environment. Certain computationally intensive components have
restrictive hardware or software requirements, so processing must be spread be-
tween multiple hosts. The architecture has been divided into distinct, independently-
functioning components with real-time communication middleware linking phys-
ical machines. Clearly-defined interfaces describe input and output of each com-
ponent and for the browser and VisApp clients.
Figure 2: Overview of web application architecture. On the far left, various
clients connect to the webserver running a SignalR Hub that, in turn, connects to
simulation, segmentation and image processing services elsewhere within a priv-
ileged network. Business logic and views are provided by a standard ASP.NET
MVC application hosted on the webserver.
The user roles discussed in §1 have highly contrasting requirements. Manu-
facturers want to add new equipment and algorithms easily. Radiologists want
to use this equipment in a simulation environment, to familiarize themselves
with a product, provide a training environment or to plan an intervention.
Finally, researchers validate simulation results against laboratory tests or real-
world clinical data, compare theoretical models, or experiment with protocol or
equipment formulations.
To address these requirements, the following autonomous services have been
implemented:
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Image visualization server Due to the computational load of certain com-
putational tasks required to support the radiological interface, a separate server
handles these independently. This service processes the DICOM, segmentation
and simulation data, generating axial, sagittal and coronal pictures which can
be used in any common browser.
In particular, image re-slicing, allowing a user to adjust the axes along which
the coronal, sagittal and axial views are defined, is a computationally demanding
task to be completed with minimal interruption to the user experience during
needle placement. Other tasks related to user-facing image generation and edit-
ing are implemented here, for example, contrast setting and editing of existing
segmentations.
Image processing server This service segments structures such as organs,
bronchi, vessel trees or tumours in the DICOM data provided by radiologists.
This functionality is described in greater detail in §2.3.1.
Simulation server The simulation service uses the segmented structure and
further information from parameters or needle positions to calculate a lesion.
As a highly adaptable and flexible series of multi-process numerical workflows,
the simulation framework is a distinct, re-usable concern, providing simple API
endpoints for the web application via the Crossbar.io middleware. This func-
tionality described in greater detail in §2.5.
On the client side, two complementary tools are available:
Browser client To use the Go-smart environment, the user needs only a
normal web browser. Consequently, there are no special restrictions on the
client machine. This is designed to provide interventional radiologists with a
classic radiology workspace. Figure 3 shows this layout for segmentation [3(a)]
and simulation [3(b)].
VisApp client When a clinician wishes to incorporate 3D interaction within
the interface, they may use a specialized desktop application that wraps the
website and injects a high-quality visualization widget into the fourth window,
alongside the axial, sagittal and coronal views. Otherwise, the interface remains
the same.
The services fulfill the basic functional requirements of the three user groups.
For optimal user experience within the web environment, a good internet con-
nection is required. In particular, the image visualization service must relay
results in real-time, as it should respond efficiently to brows-er interactions,
such as scrolling through a DICOM series, without visible latency.
The webserver system, hosting an ASP.NET application, marshalls commu-
nication between the client and server-side components. It is responsible for
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handling transmission and caching of image data to ensure a favourable trade-
off between data transfer and responsiveness. The application is designed to be
scalable as usage increases. The Go-Smart database is also hosted on the web-
server, which contains the anonymized patient data including medical images,
3D models and simulation results. To facilitate this, the open source ASP.NET
SignalR library [1] connects services with the different browser sessions. Sig-
nalR uses HTML5 WebSockets to enable bi-directional communication between
clients. If a client cannot use WebSockets, it falls back to other transport meth-
ods such as long-polling. Figure 2 shows the discussed components and the
connections between them.
2.1 Information handling
2.1.1 Patient image data and pseudonymization
Image data is primarily captured in DICOM format, as the standard format
for storing and processing data in medical imaging. The DICOM standard
is an evolving standard, maintained by the DICOM Standards Committee. A
comprehensive standard, it is formatted in 20 sections, covering over 4800 pages.
Patient data in a DICOM file is stored with ‘tags’, which may be referred to
using a tag name of the form (NNNN,MMMM) where NNNN and MMMM are
four digit identifiers.
Within a DICOM series of images, no specific metadata file exists, nor a
separate information database for the series. Instead, each image file contains
a header with the metadata content ahead of the image data itself. Individ-
ual manufacturers of image acquisition systems will output DICOM files with
private patient information often stored in non-standard tags.
The Go-Smart project involves four medical partners, who use a variety
of equipment for different treatment modalities from different manufacturers.
Medical image data has to be pseudonymized, with personally-identifiable ref-
erences replaced by Unique Identifiers (UIDs), or anonymized before leaving
the originating department. Mappings from UIDs to original cases are stored
securely only at the originating department.
Prior to transfer to an image server, data must be pseudonymized. It is
the responsibility of each department to properly perform this procedure before
using patient data in the web interface. In order to provide a consistent ap-
proach, the following strategy is in place – all DICOM images used within the
GoSmart project are pseudononymized by using an open source tool, DICOM
Browser [8]. This tool has the capability to take a script file with commands
for processing individual DICOM tags and built-in functions for the creation
of new UIDs. A consortial agreement was established that only the following
patient information should be preserved in the pseudonymized data: sex, age,
date and time of the examination.
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2.1.2 Ethics approval
IRB approval for data collection and processing within the project workflow
was obtained by leading medical partner MUL under local reference AZ 206-13-
15072013.
2.1.3 Case Report Forms
All relevant data from patient’s history – both image and clinical data – are doc-
umented within a comprehensive Case Report Form (CRF). This is available
both as an offline document and integrated into the Go-Smart system, as part
of its integrated patient record management. This document contains general
patient statistics, such as age, sex, height and weight. The preoperative section
of the CRF records characteristics of the target tumor such as size, qualitative
perfusion and relevant pre-treatments, alongside pre-operative imaging notes
and relevant blood parameters. During the MICT procedure, the exact course
of the ablation is documented, especially technical parameters like energy depo-
sition, number of needle positions, deviations from the protocol and what type
of imaging was performed during the intervention. The post-operative section
then evaluates details on follow up imaging, the size of the treatment lesion and
once again relevant blood parameters.
The CRF can be supplemented by an appendix, which contains screenshots
from key images like target tumor or other relevant imaging information. Fur-
thermore, adverse events during the treatment must be recorded here.
The use of online CRFs also provides a useful MICT database for future
collaborative research.
2.2 Usage
2.2.1 Primary user groups
Clinicians Once a clinician is logged onto the website, they may add a new
patient record, capturing some or all of the wide variety of fields contained
in standard Case Report Forms (§2.1.3). Pre-interventional CT and/or MRI
images may be attached to the patient record and segmented using a semi-
automatic process. Tailored segmentation tools are available for automatically
identifying the lung, liver and kidney as potential ablation targets (additional
organs may be added in future) and extracting a vessel tree from several con-
trast phases. With greater clinician involvement, other visible structures are
segmented also, such as tumours and regions previously targeted by TACE.
Prior to performing a procedure, clinicians may place virtual percutaneous,
needle-like probes in the segmented image, indicating the planned ablation tar-
get (Figure 3(a)). They set relevant configuration parameters, perhaps specific
to a certain manufacturer or equipment model, and define an intended treat-
ment protocol. At this point, a clinician may execute a simulation, which will
show the approximate lesion created by such a treatment (Figure 3(b)). In most
cases, this unattended simulation process takes 10-60 minutes, although shorter
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or longer computations occur for certain combinations of protocol, equipment
and modality.
After performing the procedure, clinicians may upload intra-operative im-
ages. These are then registered to the pre-operative data, which may be pro-
duced by distinct imaging modalities (CT to MRI and vice versa). This allows
the clinician to identify the actual, rather than virtual, location of the ablation
probes in the intra-operative image and so improve the simulation result.
The simulation models are tuned, by default, to predict the ablation lesion
visible four weeks after the procedure. At this time, the clinician may wish
to upload a set of post-operative images. The actual ablation lesion may be
segmented from this image semi-automatically and, by registration with the
pre-operative image, compared to the predicted outcome. A tool is provided to
quantify the match.
Researchers, developers and manufacturers For users who wish to ex-
pand the Go-Smart framework, additional workflows are available. While much
of the testing may be done using a workflow similar to that of a clinician, a
technician may use the so-called Developer Corner to add a new mathematical
model or piece of equipment.
Numerical models, needles, power generators, organs (contexts) and clinical
protocols all have their own parameters, which may be adjusted through this
interface. Technicians create their own version of a particular piece of equipment
and simulate using their adjusted parameters, or test new theoretical models or
modalities by defining tailored Elmer (finite element solver) SIF files [66] through
the Developer Corner. Support for OpenFOAM [34] and Python, including
the FEniCS libraries [49] has also been integrated. Due to the loosely-linked
Clinican Domain Model (§2.4), re-use of existing or new numerical models and
equipment is simple, allowing a techician to test a new theoretical model against
a range of manufacturers probes, or vice versa.
2.2.2 Protocols
For each treatment modality, a tightly or loosely supplied recommendation by
the manufacturer guides clinicians in the execution of the procedure. For RFA,
this is often a complex algorithm, progressing through a series of possibly repeat-
ing steps according to the electrical impedance or average observed temperature
shown on the power generator. For MWA, this is a much freer decision and clin-
icians choose a series of powers and durations to perform in sequence for each
location. In cryoablation, rather than power, flow-rate is varied at set times for
each probe. In IRE, probes are set, pairwise, to be anodes and cathodes with
a sequence of potential differences applied between them. Within all of these
protocols a degree of latitude is applied, based on clinical experience.
As such, the framework maintains a concept of a protocol , generally defined
by a technician in Elmer’s MATC language [64]. This is normally a feedback loop
that relates certain simulation variables to varying power, or another controlled
variable, over time. These protocols often define the end of the procedure.
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To allow straightforward use and customization by clinicians, these protocols
may include parameters set at simulation time, through the user interface, and
may indicate default widgets for clinician interaction (e.g. interactive power-
time-graph).
2.2.3 Result Analysis
A separate validation component in the interface allows clinicians and techni-
cians to view the registered, segmented ablation lesion in the same interactive
pre-operative image viewer as the simulated ablation lesion. Using the method-
ology described in §4, a series of comparative statistics are calculated and pre-
sented.
2.3 Application components
2.3.1 Image segmentation and registration
This component allows a patient-specific 3D model to be built for clinician
analysis and simulation, using CT and MRI images, based on a software library
developed during the project. Separate relevant entities, such as organ, vessels,
tumours and observed lesion are identified semi-automatically, with clinical sup-
port and adjustment through the radiological interface.
The target organ may be segmented fully automatically through organ-
specific tools. This is achieved through a rough decomposition of abdominal
structures into semantic objects and morphology-based segmentation.
For cases where fully automatic segmentation is not possible, a series of
‘drawing’ tools are provided – these include polygonal, slice-based inclusion or
exclusion of regions; single-click, seed-point segmentation, identifying contigu-
ous areas; and a free-hand painting tool.
Inner tubular structures, such as vessels, bile ducts and bronchi, are ex-
tracted by an altering Hessian-vessel model based segmentation method [4]. To
provide data for segmenting vessel structures, a series of images must be ob-
tained at separate phases of contrast enhancement – arterial, portal and venous.
Segmented structures within these consecutive images are matched using image
registration algorithms, and mapped into a single frame of references.
Similar techniques are used to match image data from pre-interventional
acquisitions to that of peri-interventional and post-interventional acquisitions,
with users identifying a series of corresponding landmark points in each im-
age. Pre-interventional to post-interventional registration allows validation of
ablation regions, between simulated and clinician-segmented profiles, as well as
the inclusion of needle positions segmented from intra-operative imaging in the
pre-interventional reference frame, for simulation.
2.3.2 Visualization
Using the Go-Smart web page in a browser allows a user to visually inspect
all data generated during the workflow in a 2D, slice-based representation. A
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standard radiological workstation is provided, encompassing sagittal, coronal
and axial viewers. Within this interface are tools familiar to radiologists, such
as image contrast windowing. Outline profiles of segmentation results, simulated
ablation lesions and percutaneous needles are displayed within these views.
In addition to this radiological interface, a seamlessly integrated 3D visu-
alization tool, named VisApp, is available for Microsoft Windows platforms.
It exploits the local computing power of the client PC and minimizes delays
between interaction and response. The application is implemented as an aug-
mented web browser that identifies a hook on the Go-Smart web-page, and
replaces the corresponding area with a render widget drawing from local GPU
resources. This appears alongside the axial, sagittal and coronal image windows,
providing a fourth window. This view is interactive and, using the SignalR path-
ways described in §2, causes the rest of the web-based interface to be updated
in real-time, in response to user actions in the VisApp window and vice versa.
Advanced 3D volume rendering techniques are employed, which can adapt to
the specifications of the local hardware. From basic direct volume ray casting
[48], through advanced algorithms with optimal resource exploitation [81], to
high-end global illumination techniques [40], a variety of options are supplied
to the end-user, based on the capacity of the client machine (Figure 4). Both
volumetric data and surface-based representations of segmented and simulated
results, as well as needle models, are visualized through this interface. This
allows user to explore treatment possibilities and evaluate validation data in
3D, as a supplement to traditional slice-based techniques.
2.4 Clinical domain model
2.4.1 Outline
This concept allows a database-persisted set of entities to collectively define
a simulation strategy. The approach taken is more opinionated than existing
model definition approaches (e.g. CellML, FieldML, SGML), in that it admits
only certain, generic types of structure and entity, but allows for the model
definition itself to be an arbitrary parameterized payload. As such, the clinical
domain approach allows us to wrap CellML, say, as a numerical model taking
parameters supplied by one or more clinical domain entities.
The fundamental abstract entities are:
− Context*: environmental parameter set, such as per-organ default volu-
metric constants
− Power Generator*: or any one-per-procedure parameter set. In the MICT
context, a power generator, regulator or other standalone governing ma-
chinery. Generally dynamically defined by a manufacturer
− Needle*: or any multiple-per-procedure parameter set. In the MICT con-
text, generally a specific manufacturer-model of a percutaneous needle.
Generally dynamically defined by a manufacturer
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− Protocol : a set of algorithms mapping intraprocedural variables to model
inputs. In the MICT context, generally a clinical protocol for indicating
recommended clinician interaction with the apparatus as the intervention
procedes. Generally dynamically defined by a manufacturer or clinical
researcher
− Algorithm*: a single function definition, with text body, that may be
interpreted by a particular simulation tool as mapping simulation-time
inputs to quantitative outputs. In the MICT context, a specific output
algorithm for a clinical protocol, giving, for instance, adjusted power or
protocol phase number. Generally dynamically defined by a manufacturer
or clinical researcher
− Numerical Model*: parameterized definition of numerical model or set-
tings for simulation software. In the MICT context, a parameterized Elmer
(or other FE/FV solver) simulation definition. Generally dynamically de-
fined by a medical physicist or biophysical researcher
− Combination: valid, simulatable set of the above entities. Generally dy-
namically defined by a manufacturer or biophysical researcher
− Modality : grouping of above entities, except Context, indicating a type of
treatment. In the MICT context, this is RFA, MWA, Cryoablation, IRE
(or other simulatable treatment)
− Parameter : uniquely-named, reusable token representing an item of infor-
mation, possibly with a default value, type and/or entry widget. Param-
eter names are generally in capitalized snake case (underscore-separated)
for flexibility and ease of identification. This appears as, for example,
CONSTANT INPUT POWER.
− Parameter Attribution: a specific application of a Parameter to one or
more of the starred entities, possibly with overriding value, type and/or
entry widget
− Argument : a simulatable, intraprocedural output of the intervention, such
as time or, where appropriate, power, clinical protocol phase, temperature
observered by apparatus, etc.
− Result : a simulatable output of the procedure
The relationship between these entities is depicted in Figure 5. In addition to
the Combination and Parameter Attribution relationships noted above, a many-
to-many relationship can specify physically valid linkages of Power Generator
and Needle. This helps a manufacturer to sensibly constrain the possible Com-
binations that may later be added by a clinical researcher or other downstream
user.
These entities are stratified into several layers representing abstract entities,
simulation-time entities and case-specific entities (Figure 6). Certain of these
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entities are related through concretization or measurement, that is, such entities
are derived from abstract forms supplemented by additional information, such
as processed image data or clinician-selected options.
A natural progression may be seen between each tier. Abstract entities
are defined by researchers and manufacturers. Through interaction with the
radiology-style web interface and guided parameter entry, clinicians (or other
users) create a set of simulation entities. This provides a complete set of data
necessary for executing a simulation. Many simulations may be run by various
users against a single Combination – a set of abstract definitions representing a
procedure – each simulation creating a new set of Simulation entities.
For instance, an abstract needle may have a manufacturer model number and
a range of settings. However, until it is concretized , that is, used in a simulation
or actual intervention, it does not have a spatial position or a given number of
separately configured needles. A Combination may have several possible needle
model numbers that may be used. Each abstract needle will represent a different
manufacture model. The distinction may be considered analogous to classes and
objects.
A Simulation may have only one of those needle model numbers used several
times, as separate Concrete Needles inheriting from a single Abstract Needle but
each with separate tip and entry locations. Similarly, a Simulation may have
any other repeated selection from the needle types allowed by the Combination.
In the Power Generator – Needle cross-over table, a manufacturer may specify
the minimum and maximum number of needles that may be used with a single
generator, and so for a given simulation using that Power Generator. In a
more general sense, this provides a separate relationship limiting the allowed
combinations of one-per-simulation entity and multiple-per-simulation entities.
The third tier represents a set of physical facts relating to the specific inter-
vention and/or patient, such as patient-specific measurements, image analysis
and intervention outcomes. Some of this data may be used to create a Sim-
ulation, such as the segmented surfaces, or to validate it, such as measured
outcomes.
2.4.2 Interaction of entities and workflow
An example workflow is presented showing the creation of entities defined above
in normal practice. For simplicity, an example is chosen where the manufacturer
defines exactly and only the equipment, a researcher prepares a protocol and
numerical model, and a clinician runs a simulation based on their definitions.
Abstract Tier: Creating Combinations
Manufacturer When a manufacturer creates a Needle or Power Genera-
tor, a new entity in the Abstract tier is created. The manufacturer defines its
characteristics through Parameters – these may be additionally constrained to
vary by organ (Context), say, or when paired with an existing clinical protocol
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(Protocol). In the case of a Needle, a geometric definition may also be pro-
vided. Parameter Attributions link equipment entities to each Parameter – if a
Parameter does not exist with that name, one is created.
For each Parameter required, they may indicate whether a clinician can (or
should) fill in a value, and what form widget to use, or whether a Combination
including their equipment should only be definable if this Parameter has been
given a value by another component of the Combination.
Researcher A researcher may add a numerical model to enable simulation
of treatments. They prepare an entity-agnostic numerical model, for instance,
using FEniCS and other scientific Python libraries. That is, it does not de-
pend on the choice of Context, Needles, Power Generator or Protocols, but
only on Parameters. They create a JSON file, declaring required Parameters
and providing default values if appropriate. In Python, a helper module exists,
which researchers may use to access Parameter and Region information (Exam-
ple 1). When using the standard simulation workflows, for Elmer and FEniCS,
researchers can assume a volumetric mesh has been provided in GMSH MSH
format before their code runs, and all volumetric and boundary subdomains
have known indices. The researcher may indicate required regions, with ad-
missible multiplicities, in their model definition – these will be supplied by the
output of the segmentation tool-chain.
Parameter values may be any JSON-representable type, although basic types
provide most flexibility.
Example 1 Python snippet based on an IRE Numerical Model. This converts
the CGAL-supplied mesh to DOLFIN format and loads it. IRE electrode data is
loaded from a Parameter and the mesh indices for vessel regions are extracted
as integers. These may then be used for providing, e.g., boundary constraints
and solving using FEniCS.
from gosmart.parameters import P, R
import dolfin as d
import subprocess
subprocess.call([
"dolfin-convert",
"/shared/output/run/input.msh",
destination xml
])
mesh = d.Mesh(destination xml)
electrode triples = P.CONSTANT IRE NEEDLEPAIR VOLTAGE
vessel mesh indices = [r.idx for r in R.group(’vessels’)]
In the Elmer case, using Jinja2-templated SIF files (http://jinja.pocoo.org),
the syntax for Parameter access is similar.
For each Parameter required, a researcher may indicate whether a clinician
can (or should) fill in a value, and what form widget to use, or whether a
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Combination including their model should only be definable if this Parameter
has been given a value by another component of the Combination.
Combination creation Either the researcher or manufacturer may add
a new Combination, or set of Combinations, to make use of these models and
equipment. All Simulations are based on an existing Combination.
Each Combination includes a single Numerical Model, Power Generator,
Context, Protocol (which may be trivial, not supplying any algorithms) and
one or more Needles. When a Combination is defined, the system confirms that
all Parameters defined by a member of the Combination are either filled with
default values, or allow values to be provided at simulation-time. Otherwise, it
will refuse to create the Combination – this provides a crucial validation step,
ensuring equipment and contexts, such as organs or phantoms, are pairable with
the numerical models.
Simulation and Case Tiers: Using Combinations
Clinician A non-technical user, or technical user following their workflow,
will upload patient data or experimental data. This creates certain Case Tier
entities, such as defining a specific concrete context, indicating that this case is
in a human liver, say, or an ex vivo muscle sample. The segmentation process
identifies a series of regions with concrete geometric extents.
The user may then wish to run a Simulation. Only existing Combinations
may be used for Simulation. The user picks a Power Generator and Clinical
Protocol they wish to use via HTML drop-down boxes. None, one or more
Needles (as permitted by the model) are added by the user via another drop-
down box. The user identifies a tip location and organ entry-point for each by
clicking in the radiology planes. These Concrete Needles, a series of Abstract
Needles augmented with a specific geometric location, are saved.
Once the Needles are placed, only the Numerical Model remains a free selec-
tion. For each such selection, the administrator chooses one Combination to be
marked public, to avoid non-technical users ever being confronted with a choice
of Numerical Models. However, this public marker does not apply to technical
users, and they are presented with a final drop-down menu of Numerical Models.
This process specifies the Combination completely, and the associated Pa-
rameters which have been marked for clinician input are presented in a user-
friendly HTML form, alongside the radiology view. When they finally execute
the Simulation, the Parameter values are saved as Concrete Parameters attached
to the Simulation. They are no longer related to their source entity, except in
the case of Needle Parameters, which are then tied to the Concrete Needles
added above.
The Simulation definition is sent to the simulation orchestration tool via
WAMP middleware. In the Go-Smart context, this is a transition from a .NET
web application to one or more Linux back-end hosts.
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2.5 Simulation orchestration
In creating a new simulation, the synthesis of members of a Combination into
a single set of simulation settings is the responsibility of the web infrastruc-
ture, rather than the simulation orchestration tool. To enable clean exchange of
model settings, without leakage of entity identities, a simple XML sublanguage
has been defined: GSSA-XML. This contains only Simulation tier information
necessary to execute a numerical analysis (i.e. that required by the Numerical
Model entity). Its purpose is to prevent entity-specific behaviour on the simu-
lation side, and ensure application-side entity extensibility independent of the
simulation tool.
The orchestration tool that converts GSSA-XML into workflow-specific set-
tings and launches individual simulation containers, is an open source package
named Glossia, developed as part of Go-Smart. It hooks into the middleware by
providing a series of WAMP end-points. While any WAMP router is adequate, a
sample configuration is provided for the Crossbar.io software. This architecture
enables a simulation to be executed and monitored from a process on any ac-
cessible machine in any language that has WAMP bindings. Glossia interaction
has been tested from C#, Python, PHP and Javascript clients. The language
of the workflow tools, inside the simulation container, is entirely independent of
Glossia.
The Glossia server accepts a GSSA-XML simulation definition and examines
it for a specific Numerical Model family – this is part of the Numerical Model’s
entity definition. A family is defined to be a pair: a specific Docker image for
performing numerics and a Python ‘mortar’ module, used to translate GSSA-
XML into the necessary numerical package configuration. For Python-scripted
simulation workflows, which can import the Glossia Python Container Mod-
ule, no additional plug-in is required, making the creation of additional Docker
families simpler. The developer may access all needles, parameters and com-
putational regions through this module as normal Python structures, leaving
communication detail to the Glossia tools.
For a given family, the configuration may be very general. In the case of the
FEniCS [49] family, the configuration is a numerical Python module that may
use any of a range of numerical Python libraries accessible inside the container,
and possibly not the FEniCS library itself.
2.5.1 Docker simulation containers
The usage of Docker in non-scientific contexts has developed rapidly over the
last two years. It provides lightweight, walled-off environments, with many
of the benefits and few of the drawbacks of virtual machines. In particular,
performance is similar to what may be seen without containerization. It is in
production, providing user sandboxing for many Platform-as-a-Service (PaaS)
providers. Its use in science and medicine is gradually being explored, as aware-
ness of and experience in these technologies spreads from the web development
and computer science.
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As well as supporting a secure environment to run untrusted code, it allows
reproducability, ensuring that a researcher’s code will run on the Glossia server
exactly as it does on the researcher’s personal workstation. To facilitate this,
all Glossia tools are provided as open source software (https://github.com/go-
smart), mostly under the Affero Gnu Public License (AGPL). Example families
are included, wrapping the FEniCS and Elmer [66] numerical suites.
The AGPL requires a third party that wishes to provide a Go-Smart-like
web service using Glossia to release any incorporated Glossia modifications, in-
cluding addition of ‘mortar’ modules. However, the contents of new simulation
container images or separate software on the host are not affected by this license
and may be kept private (notwithstanding licensing restrictions of other soft-
ware components). Libraries for use inside containers are provided under the
MIT license, allowing proprietary or private code to be used for simulation if
desired. The sale of more relaxed licensing is a potential component of project
exploitation.
3 Theory of Minimally Invasive Cancer Treat-
ments
The core mathematical models for simulating a series of ablation treatments
are outlined. All are implemented, for the purposes of the web interface, using
the Elmer framework, although some have purpose-written research implemen-
tations also in Python (FEniCS) or OpenFOAM. In most cases, the simulation
process takes 10 - 60 min, unattended, for adequately refined results. However,
as the environment permits on-going improvement and refinement of models,
timing statistics are not fixed. While these models are based on established,
published algorithms, additional project research has refined them and allowed
identification of key patient-specific parameters [29].
3.1 Common Models of Thermal Modalities
Several of the modalities function by using hypo- or hyperthermia to destroy
tissue. Two models, in particular, are thus shared:
3.1.1 Bioheat equation with perfusion term
As evidenced by analysis during the IMPPACT project [39], [57], and following
work of Kro¨ger et al [46], a basic Pennes bioheat equation with added perfusion
term is adequate to model first order effects of the thermal modalities. This
formulation is used in a variety of numerical approaches to MICT modelling [9].
The governing equation is,
ρc∂tT − k∇2T = Qinst +Qperf ,
where ρ, c, k and T are the density, specific heat capacity, heat conductivity
and temperature of the perfused tissue, respectively. Qinst represents the heat
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flux due to the ablation instrument. The norming effect of tissue perfusion is
defined to be,
Qperf(x) =
{
νρbcb(Tbody − T (x)) if D(x) > D0,
0 otherwise
with x being the spatial coordinate, D(x) indicating the local fraction of cells
considered dead and D0. The perfusion coefficient, ν is a material property of
the local medium (e.g. lung tissue, liver tissue, tumour tissue), Tbody is standard
body temperature and T is the current local temperature. ρb and cb represent
the density and specific heat capacity of blood. Note that perfusion here is
taken to be a field value, representing the thermal effect of blood-flow in vessels
smaller than the imaging resolution.
3.1.2 Cell death model
While under hypothermia a simple empirical isotherm is used, for the case of
hyperthermia, a more complex cell death model is used, developed during the
IMPPACT project [53]. Cells exist in one of three states: Alive, Vulnerable and
Dead. Cells may transition from being Alive to being Vulnerable, from being
Vulnerable to being Dead and from being Vulnerable to being Alive. The rates
at which they do so are dependent on local temperature.
The fraction of cells at a location in an Alive, Vulnerable or Dead state is
expressed in terms of A, V and D, respectively. Each variable lies between 0
and 1 and the sum of all three is consistently 1.0 – this allows the Vulnerability
variable to be removed from the algorithm. The relationships are expressed as
follows,
dA
dt
= −k¯feT/Tk(1−A)A+ kb(1−A−D),
dD
dt
= k¯fe
T/Tk(1−A)(1−A−D),
A|t=0 = 0.99, D|t=0 = 0.0
The forward and backward rate coefficients, kf and kb may be constants or
temperature dependent. By default, the lesion is estimated to be the region in
which D > D0 := 0.8.
3.2 MICT-Specific Models
3.2.1 Microwave ablation
This modality is modeled by coupling the above bioheat equation and death
equation to a simplified Maxwell’s Equations solver. The local value of Qinst
is calculated using a transverse-magnetic (TM) axisymmetric cylindrical solver.
The primary equation is,
∇×
[(
εr − i σ
ωε0
)−1
∇×H
]
− µrk20H = 0, (1)
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where εr and σ are temperature-dependent relative permittivity and conduc-
tivity of tissue, respectively, at the manufacturer’s stated frequency. z and r
are the local cylindrical coordinates along the probe shaft and centred on its
tip. k0 and ω are the wave number in a vacuum and angular frequency, respec-
tively. H = Hφeφ is the magnetic field vector, approximated as having only
an azimuthal component, Hφ. This may be used to calculate the local energy
deposition into the tissue (SAR), through the relationship,
Qinst =
1
2
σ|∇H|. (2)
As parameters in Equation 1 are temperature dependent, we can see the non-
linear coupling between the bioheat and coax equations. Unlike the simpler,
linear model, without temperature dependent electromagnetic parameters, the
nonlinear coupled problem tends to a steady-state solution over relatively short
timescales. The steady-state magnetic field is obtained from the axisymmet-
ric model with a fine resolution numerical mesh. This then supplies ∇H for
Equation 2, which may be used with temperature-varying σ in a time-stepping
bioheat model. This enables microwave simulation to be performed in clinically
applicable times.
The current model is based on the Amica Microsulis prototype probe, al-
though on-going work is incorporating a second manufacturer’s configuration.
3.2.2 Cryoablation
While the basic model for this is the modified Pennes bioheat equation, a front-
capturing multi-phase solver is used to ensure accurate representation of the
change in physical properties due to the expanding ice ball. In particular, the
numerical method used is the effective heat capacity method . Here, the latent
heat of phase change is accounted for by an adjustment to the relationship
between specific heat capacity and temperature. Moreover, a mushy region is
admitted, permitting a smooth transition of physical properties. Mathemati-
cally, the effective heat capacity is given as,
ceff(T ) =

cs, T < Ts,
cs+cl
2 +
hsf
2(Tl−Ts) , Ts 6 T 6 Tl,
cl, T > Tl,
where hsf is the latent heat of solidification, T is temperature, c is heat capacity
and the subscripts l and s denote the solidus and liquidus states, respectively.
The thermal conductivity is then defined to be,
keff(T ) =

ks, T < Ts,
ks +
1
2(Tl−Ts) (kl − ks)(T − Ts), Ts 6 T 6 Tl,
kl, T > Tl,
where k is thermal conductivity. These effective values replace their equivalents
in the Pennes bioheat equation and the resulting nonlinear equation is solved
iteratively.
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This model and protocol has been tested against ablations performed using
Galil Medical Systems’ cryoablation technology.
3.2.3 Irreversible electroporation
IRE is modeled using a simple electric potential solver,
∇ · (σ∇φ) = 0,
∂φ
∂n
|Ai = Vi,
∂φ
∂n
|Ci = 0,
with conductivity σ and electric potential φ. Ai and Ci are the i
th anode and
cathode, respectively, and Vi is the defined potential difference between them.
Over the ordered sequence of pairings in the protocol, each of which is de-
fined by two of up to six probes and their potential difference, the electrical
properties change based on the deposited energy. The final lesion is defined as
an isovolume based on a chosen threshold of the local energy maximum over the
whole protocol sequence [60, 24]. Future work is required to determine precise
parameters for heuristic thresholds.
3.2.4 Radiofrequency ablation
Rather than performing a Joule heating simulation for each execution of this
modality, an empirical approach is generally used, consisting of a summation
of Gaussian functions centred on suitably chosen points. This technique was
validated during the IMPPACT project, and avoids the extremely large meshes
required to capture the < 1 mm diameter probe tines. Further studies using
a calculated Joule heating field are planned. This model is tailored to the
Angiodynamics RITA family of RFA needles, although extension work is on-
going to incorporate extensible-tine probes of another manufacturer.
The RFA power generator simulation accounts for the feedback loop based
on the thermocouples at the tips of individual tines. Recommended clinical
protocols may be followed automatically, where the simulation moves from one
protocol step to the next based on temperature readings, for instance. Tines
may be extended or retracted according to the protocol, and the input power
is governed by a PID controller, with temperature as the primary variable (for
RITA needles).
3.3 Extension
Mathematical models applied to other areas of the body or treatment method-
ologies may be integrated by creation of finite element configurations for already-
incorporated simulation families, such as Elmer or FEniCS. As these families
are modular, third party tools may be incorporated by the server administra-
tor, as a separate Docker image, with preprocessing Python plug-in modules.
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Numerical models built on top of this new family may be defined in any way
parsable by the plug-in module and container image.
4 Results & Discussion
Sample results obtained using the Go-Smart workflow, demonstrating the effec-
tiveness of the procedure, are presented. In keeping with the focus of the current
work on simulation orchestration and model-building methodology, full valida-
tion studies examining the effectiveness of biophysical models of each MICT
procedure will be the subject of future treatment-focused communications.
It should be reinforced that, within the context of this paper, our primary
demonstration through these results is the effectiveness of the system for bring-
ing together parameters, models and patient-specific data into representative
simulated outputs. Full analysis and detailed validation of the models them-
selves is provided separately.
4.1 Evaluation measures
To provide evaluation of simulation performance, the ablation lesion as observed
4-6 months after the intervention is used as a reference. This is segmented by
clinicians through the interface and may be registered into the same coordi-
nate system as the pre-interventional segmentations, on which the simulation is
based.
For demonstrating applicability to end-user workflows, comparison of size
and shape is of primary interest. As organ-based registration between the pre-
and post-interventional image acquisitions is affected by alterations in the rel-
ative locations of internal structures over the 4-6 week intervening period, a
rigid-body registration is applied between the segmented and simulated ablation
lesions. While this prevents us from measuring offset, it allows us to quantify
shape and size deviation between the two ablation zones. Potential effects of
this approach on measuring simulation accuracy are raised in the discussion of
results.
The segmented ablation lesion volume, after rigid-body registration, is de-
noted S. The simulated ablation lesion volume is denoted Σ. Measures pre-
sented here are the DICE metric [DICE], target overlap or sensitivity [SN], pos-
itive predictive value [PPV] and average absolute error [AAE]. Measures used
are established measures in image comparison ([41, 9]). These are defined as
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follows:
DICE =
2|S ∩ Σ|
|S|+ |Σ| ,
SN =
|S ∩ Σ|
|S| ,
PPV =
|S ∩ Σ|
|Σ| ,
AAE =
∫
∂S
{ inf
y∈∂Σ
|x− y|}dx/|∂S|.
The DICE, SN and PPV values range from least match at 0.0 to identical overlap
between S and Σ at 1.0. While the DICE value is symmetric, the SN and PPV
together help indicate the dominant type of mismatch – false positive or false
negative. The AAE value is an average of the minimum distance to a point on
Σ from each point on S, and helps isolate surface comparison when considered
alongside the volumetric measures. The mean, µ, and standard deviation, σ, of
each measure is presented. The volumetric ratios are unitless. AAE is measured
in millimetres. All values are rounded to 3d.p.
4.2 Radiofrequency ablation
Organ DICE SN PPV AAE (mm)
RFA1 Liver 0.591 0.828 0.459 3.853
RFA2 Liver 0.711 0.818 0.628 3.393
RFA3 Liver 0.631 0.661 0.604 2.975
RFA4 Liver 0.657 0.503 0.946 2.957
RFA5 Liver 0.694 0.785 0.622 2.792
µ 0.657 0.719 0.652 3.194
σ 0.043 0.123 0.160 0.384
Table 1: Evaluation measures for a series of RFA treatments
All radiofrequency ablation interventions presented in Table 1 were per-
formed at the Leipzig University Hospital [DE]. Through the web interface,
clinicians at this institution uploaded patient image data, segmented and regis-
tered it, then prepared RFA simulations to match their treatment.
Cases RFA1-RFA5 do not generally show a larger SN value than PPV value
or vice versa, suggesting that the simulated ablation zone is not systematically
over- or under-estimating the segmented ablation zone size. The AAE is steady,
2.792 mm - 3.83 mm, indicating a fairly consistent shape deviation. Where the
AAE is larger, the PPV is significantly lower than the SN, suggesting that these
higher deviation cases are due to a overestimation of the true lesion size by the
model.
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The most and least severe deviations (as measured by AAE) are shown in
Figure 7. In both cases, shape deviation can be seen between the registered
segmented ablation lesion in purple and the simulated ablation lesion in organ.
This similarity of shape deviation corresponds to the similar observed AAE val-
ues. The simulated RFA heat deposition profile is based on research outcomes of
the IMPPACT project, and it is generally observed that segmented RFA lesions
form approximations to this pattern. Both lesions were produced with Rita
Starburst needles using a staged protocol, recommended by the manufacturer,
intended to produce a 5cm-diameter lesion. The clinical steps and responses in
this protocol are algorithmically defined in the Go-Smart database.
Not shown in Figure 7, to avoid obscuring the view of the ablation lesions,
is the vessel tree. The effects of this structure may be seen to the far right of
the simulated ablation in Figure 7(a), where the lesion profile curves inwards.
The percutaneous needle is not shown - in both cases it lies approximately
on the vertical axis, entering at the bottom of the figure and, in Figure 7(a),
terminating inside the green tumour surface. The individual flexible tines of
the Rita Starburst probe extend at separate stages of the protocol and lie a few
millimetres inside the simulation extent shown.
In Figure 7(a), the clinically segmented lesion is shown prior to rigid-body
transformation (in charcoal). The transformed version is shown in purple. The
inaccuracy of the original 1-2 month follow-up registration may be seen by the
offset of the tumour, which is segmented in the pre-interventional image, from
the charcoal profile. In contrast, the base of the simulated lesion mostly covers
the tumour. However, there may be a small local underestimation here, as no
indication of under-treatment was given in the clinical report form (CRF). For
clarity, only the transformed version is shown in most subsequent figures.
4.3 Microwave ablation
Organ DICE SN PPV AAE (mm)
MWA1 Liver 0.503 0.349 0.903 3.682
MWA2 Lung 0.545 0.466 0.657 5.305
MWA3 Liver 0.722 0.579 0.958 2.285
MWA4 Liver 0.722 0.603 0.901 2.278
MWA5 Lung 0.650 0.517 0.870 4.071
µ 0.628 0.583 0.859 3.524
σ 0.090 0.091 0.104 1.15
Table 2: Evaluation measures for a series of MWA treatments
All microwave ablation interventions presented in Table 2 were performed at
the Medical University of Graz [AU] (Liver) and University Hospital Frankfurt
[DE] (Lung).
Cases MWA1-MWA5 generally have significantly larger PPV values than
SV. All three cases performed in the liver have PPV values over 0.9, although
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only two have DICE values over 0.7. The liver cases have a smaller AAE, with
values between 2.2 mm and 3.7 mm, compared to the lung cases, with the AAE
values of both being over 4.0 mm. This suggests that, both in the lung and in
the liver, the MWA model may be consistently over-estimating the extent of
the ablation lesion. The moderate AAE values in the liver suggest that there
it is more accurately reflecting the shape than in the lung. Overall, the mean,
µ, is similar to the RFA cases, but the standard deviation, σ, is much larger,
approximately treble the presented RFA example.
In Figure 8, as in the RFA discussion, the two MWA cases with greatest
and least AAE values, respectively, are shown. Alongside the vessel tree, an
additional segmented structure is present in the lung simulations, the bronchi
(not shown). In both images, it can be seen that the MWA profile forms an
approximately obloid shape. While this is produced using bioheat transfer and
a deposition profile derived from Maxwell’s electromagnetic equations, the sim-
ulated ablation region is similar in profile to descriptions in manufacturers’
literature.
The case with greater deviation, MWA2, is shown in Figure 8(a). The
clinician-segmented tumour and ablation zone are significantly offset from the
clinician-segmented needle. The simulation itself matches the needle location
well and in one dimension, has similar extent to the segmented ablation lesion.
However, in the directions perpendicular to the line of view, the segmented abla-
tion has a much larger extent. In the second case, MWA4, shown in Figure 8(b),
a much better match is visible. The tumour is mostly, but not entirely, covered
by the simulation. The ablation extent in line with the needle is underestimated,
however.
In the lung context, registration is considerably more challenging due to
the large deformations in the medium, and this may contribute to the discrep-
ancy observed in MWA2. In general, observed ablation profile deviations in
the liver tend to be smaller. In addition, the MWA energy deposition profile
is heavily dependent on the ablation probe’s internal geometry, thus the equip-
ment model and manufacturer. While we have been able to produce models
based on prototypal probe geometries, this specificity is believed to contribute
to ablation underestimation in MWA4 and other liver and lung cases. A second
manufacturer-specific geometry is under development.
4.4 Cryoablation
All cryoablation interventions presented in Table 3 were performed at the Rad-
boud University Medical Centre [NE].
Performance in the CRYO1-CRYO5 cases is generally good, although no
consistent pattern of under- or over-estimation is easily observable. The AAE
values are generally low, although in CRYO1, all volumetric measures are below
0.74. CRYO5 has similar volumetric measures, but its AAE value is below 1.9,
suggesting that deviation may be a relatively small offset. In CRYO3, an even
lower AAE value is seen, but the SN value is the second lowest of the set,
perhaps indicating that the segmented ablation in this case is uniformly larger
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Organ DICE SN PPV AAE (mm)
CRYO1 Kidney 0.619 0.553 0.739 2.905
CRYO2 Kidney 0.755 0.960 0.622 2.368
CRYO3 Kidney 0.796 0.682 0.955 1.591
CRYO4 Kidney 0.828 0.821 0.835 2.240
CRYO5 Kidney 0.743 0.748 0.739 1.859
µ 0.748 0.749 0.778 2.19
σ 0.071 0.142 0.111 0.450
Table 3: Evaluation measures for a series of cryoablation treatments
than the simulated profile.
As before, in Figure 9, the two cryoablation cases with greatest and least
AAE values, respectively, are shown. While MWA and RFA are simulated
using one needle embedded at a time, both cryoablation and IRE must cater
for multiple needles simultaneously embedded in the computational mesh, as in
Figure 9(b).
While the sizes are broadly similar, deviation is visible in CRYO1 both
in shape and orientation. The tumour is not completely covered by either the
segmented or simulated ablation, although there is a region of three-way overlap
towards the base of the probe. Toward the tip, the probe itself leaves the organ,
as well as the lesion regions - while heat transfer is simulated outside the organ
in the cryoablation model, tissue necrosis is evaluated only inside the segmented
organ region. All cryoablation cases considered using this tool are treatments of
exophytic tumours and we see, both in CRYO1 and CRYO3, that the organ wall
provides a limit for the segmented lesion. CRYO3 also shows needles exiting
the lesions and organ, although the match between lesion extents is better.
The segmentation or registration may account for some of the difference
between CRYO1 and CRYO3 accuracy, as we can see the segmented lesion
follows the organ wall more accurately in the second case, but the simulation
nevertheless underpredicts the breadth of tumour. While the proximity to the
organ wall improves several aspects of the segmentation and registration process,
it introduces additional complication into the modelling process, as the current
model has little contextual information about the medium beyond the organ
wall. Future evolutions may include additional segmented regions abutting the
organ wall, allowing more accurate heat transfer modelling near the needle tip.
4.5 Irreversible electroporation
All irreversible electroporation interventions presented in Table 4 were per-
formed at the Medical University of Leipzig [DE].
The IRE1-IRE5 cases show a variety in quality. The PPV values in cases
IRE3 and IRE4 are very low, but more acceptable in other cases. The SN values
are generally high with AAE inversely following the PPV, suggesting that the
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Organ DICE SN PPV AAE (mm)
IRE1 Liver 0.541 0.888 0.389 5.264
IRE2 Liver 0.588 0.859 0.447 3.944
IRE3 Liver 0.088 0.996 0.046 11.767
IRE4 Liver 0.086 0.944 0.045 13.024
IRE5 Liver 0.569 0.905 0.415 8.471
µ 0.374 0.917 0.268 8.48
σ 0.234 0.049 0.182 3.53
Table 4: Evaluation measures for a series of irreversible electroporation treat-
ments
segmented ablation zones generally lie inside the simulated zones. The standard
deviation in DICE and AAE, particularly, is much higher than in previous cases,
suggesting that cases may be mixed between adequate prediction and inaccurate
results.
In Figure 10, case IRE2 and case IRE4 are shown. In IRE2, we can see that
for a small number of needles, close together, the cross-sectional size is similar,
although the extent lateral to the needles is greater. In IRE4, the segmented
ablation lesion lies mostly between the needles, intersecting only two. It covers
little of the tumour, although no residual tumour tissue was identified in the
follow-up acquisitions for this case. While the simulated ablation does cover the
tumour and needles, it is considerably bigger than the segmented ablation.
In general, the IRE cases tend to match either acceptably well, or signifi-
cantly over-estimate the observed lesion. In the latter cases, a segmented lesion
disjoint from at least one needle is observed, an unlikely occurence in the ac-
cepted physical theory, and consultation of the relevant medical images confirms
that the segmentation matches the measured data. A possible explanation is
that the necrotic tissue caused by the IRE ablation beings the healing process
faster than in thermal modalities. This is supported by the absence of both
tumour tissue and a visible ablation lesion across much of the original tumour
extent. Preliminary work has taken place to compare simulated IRE lesions with
lesion extents observed immediately post-intervention, rather than 1-2 months
later, showing much more favourable comparison.
4.6 Project outcomes
The development of the Go-Smart tool gave rise to a number of key lessons that
were learned and incorporated:
Microservices architecture To enable a scalable and resilient service, de-
ployable locally or in the cloud, components must be cleanly articulated and
re-usable.
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Domain model spanning clinical and technical concerns To facilitate
generic, open-ended simulation, relevant domain knowledge within the unified
model must not be from a single sphere, but reflect both practical and theoretical
modelling considerations.
Familiarity of interface For a system to be usable by interventional radi-
ologists, the workflow must be a variation on standard interfaces. In partic-
ular, simulation definition must fit neatly within established tool layouts, and
dynamically-added parameters should contain definitions for user-friendly wid-
gets and labelling.
Status updating For longer, non-interactive steps, status updates should be
provided, both for technical users to analyse progress and non-technical users
to indicate continued processing. This necessitates a live, multi-step communi-
cations relay from the containerized simulation, through the simulation orches-
trator, middleware and back to the client.
Broad clinical feedback is vital Having interventional radiologists using
the system and analysing (pseudonymized) patient data within it is essential
to provide insight for technical users into clinical issues with the system and to
gather information on potential edge cases with patient imaging.
Interaction with manufacturers is needed to provide quality models
Especially in multiphysics biomedical problems, manufacturer data and feed-
back is required to ensure modelling starts from an accurate basis.
In trials, patient-specific modelling requires on-going engagement be-
tween clinicians and modellers While Clinical Report Forms are the fun-
damental tool in contextualizing image data, there must be case-by-case dis-
cussion between clinicians and technical users to identify shortcomings in mod-
elling, unpredicted issues and potential errors in parameter interpretation or
measurement. In particular, an expertise gap between numericists’ awareness
of clinical received knowledge, and clinical understanding of biophysics mod-
elling concerns, may only be adequately addressed by in-depth discussion of
individual interventions.
5 Conclusions
This work has outlined a web-based platform, applied to image-guided Mini-
mally Invasive Cancer Treatments, that serves the needs of clinicians, manu-
facturers and researchers simultaneously. To achieve this requires a conceptual
model spanning the clinical and modelling concerns. For researchers, this multi-
stage approach allows them to deploy new models or computational routines to
the web-based platform with minimal additional burden. For manufacturers,
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this provides a tool to demonstrate their products and increase awareness within
the market. For clinicians, this provides a platform for training, collaboration
and knowledge gathering.
The models used for Minimally Invasive Cancer Treatment were shown to
be adequate for demonstration purposes and sufficiently varied to establish the
necessary flexibility of the Go-Smart platform. Improvements, both in terms of
speed and accuracy, may be made incrementally, and as a collaborative exercise
through the web interface. At present, our models produce most favourable
results for cryoablation, where bioheat transfer is the primary modelling chal-
lenge, and RFA, where a heuristic approach has been established. In microwave
ablation, the sensitivity of the models to manufacturer-specific geometry and
complexity of electromagnetic modelling remain a challenge. In IRE, the time-
based definition of an ablation zone must be revisited.
Interaction between stakeholders of multiple groups is essential for develop-
ment of reliable and, ultimately, clinically useful models. A process for facili-
tating this is required, and the refinements made during the Go-Smart project
in response to user feedback have helped streamline it as an appropriate.
Producing a system that allows for extension of simulation capabilities by
end-users of the web-interface has been achieved at a lower level than we have
seen, although deployment of entirely new solver frameworks remains an admin-
istrative task. More generally, the cross-concern conceptual model and toolchain
for containerized simulation orchestration is designed to be re-usable in other
clinical application domains.
5.1 Future work
On-going trials with external technical groups are underway, within a MICT
equipment manufacturer and a non-MICT-related biomedical research group.
Alongside clinical feedback, this will provide us with a useful corpus of usability
information to refine the current workflow.
To provide broader applicability, with low entry burden, existing open source
medical simulation tools, such as SimTK [71], Chaste or OpenCMISS, may be
pre-emptively incorporated as new Glossia families. In particular, wrapping
Taverna or Galaxy as new families would allow much more complex workflows
to be built, and be executable within our current architecture. Extending pre-
liminary work (using Vigilant1) to a more user-friendly set of web-based back-
end tools, providing orchestration visualization and interactive log aggregation,
will simplify management of simulation deployments in a cloud setting.
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(a) Segmentation View
(b) Simulation Preparation
Figure 3: Screenshots of workflow using in-browser client. Browser used is
Google Chrome
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Figure 4: Example output of VisApp renderer on high quality setting
Figure 5: Overview of relationships between fundamental entities. Red solid
lines indicate component entities of a combination (needles with multiplicity),
green dashed lines indicate parameterizable entities. White lines indicate (usu-
ally textual) definitions stored in the persistence layer, that is within the entity’s
record.
43
Figure 6: Clinical domain entities arranged in Abstract-Simulation-Case (ASC)
tiers. Concretization (or measurement) relationships are indicated by bracket
lines on far right.
(a) RFA1 (b) RFA2
Figure 7: Radiofrequency ablation profiles for two cases. Purple: simulated
lesion; orange: simulated lesion; green: tumour [in (a)]; charcoal: segmented
lesion before rigid body registration [in (a)]; light-grey outline: organ
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(a) MWA2 (b) MWA4
Figure 8: Microwave ablation profiles for two cases. Purple: simulated lesion;
orange: simulated lesion; green: tumour; charcoal: segmented lesion before
rigid body registration [in (a)]; light-grey outline: organ; blue cylinder: ablation
needle
(a) CRYO1 (b) CRYO3
Figure 9: Cryoablation profiles for two cases. Purple: simulated lesion; or-
ange: simulated lesion; green: tumour; light-grey outline: organ; blue cylinder:
ablation needle
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(a) IRE2 (b) IRE4
Figure 10: Irreversible electroporation profiles for two cases. Purple: simulated
lesion; orange: simulated lesion; green: tumour; light-grey outline: organ; blue
cylinder: ablation needle
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